Nicotinic Acetylcholine Receptor Signaling Activates Beige Adipocytes and Mediates Systemic Metabolism

Area of Science:

• Metabolic research
• Adipose tissue biology
• Neuroendocrinology

Background:

• Beige adipocyte activity, regulated by CHRNA2, impacts adipose function and systemic metabolism.
• The CHRNB2 subunit is crucial for nicotinic acetylcholine receptor agonist response in beige adipocytes.
• Cholinergic signaling in subcutaneous adipose tissue diminishes with age.

Purpose of the Study:

• To investigate the role of CHRNB2 in beige adipocyte function and metabolic adaptation.
• To explore the therapeutic potential of CHRNB2 partial agonists for metabolic disorders.

Main Methods:

• Utilizing Chrnb2-deleted mice to assess cold adaptation and diet-induced obesity.
• Examining the effects of CHRNB2 partial agonists on murine and human beige adipocytes.

Main Results:

• Chrnb2 deletion in mice impaired cold adaptation in subcutaneous adipose tissue.
• Mice lacking Chrnb2 exhibited worsened metabolic dysfunction when fed a high-fat diet.
• Aging led to a decline in cholinergic signaling within subcutaneous adipose tissue.
• CHRNB2 partial agonists effectively activated both mouse and human beige adipocytes.

Conclusions:

• CHRNB2 is essential for beige adipocyte function, cold adaptation, and metabolic health.
• Targeting CHRNB2 with partial agonists presents a potential therapeutic strategy for metabolic dysfunction and obesity.